Torres, Mark Jezer .

HRN: 27-39-92  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/27/2026
02/03/2026
IV
500MG
Q8H
EMPYEMA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: